BioGaia Gets Private Equity Backing To Fuel Growth
Executive Summary
Probiotics specialist BioGaia will draw on the experience of its new private equity investor EQT as it looks to expand through acquisitions and increased digitization.
You may also be interested in...
Top 20 Consumer Health Deals 2020: Private Equity And OTC Exits Drive M&A
HBW Insight reveals the biggest consumer health deals of 2020, and identifies growing private equity investment, portfolio streamlining by major players and pharma firms exiting OTC as the major drivers of M&A activity.
EU Business Round-Up: BioGaia Held Back By COVID, Nutrinovate Acquires Vitamin Sprays, Labomar Goes Public
Latest EU business news: Sweden's BioGaia warns sales to slump due to COVID-19; Nutrinovate acquires vitamin sprays firm A to K; and Italy's Labomar prepares for M&A following IPO.
Scientific Evidence And E-Commerce Key To Seizing The Probiotic Opportunity
Exclusive: CEO of global probiotic firm BioGaia, Isabelle Ducellier, speaks to HBW Insight about the company's science- and e-commerce- based growth strategy.